Texas Instruments now trades above the consensus price target — a reversal that makes this week's note less about the bull case and more about whether the Street can keep up.
The valuation arithmetic has flipped. The mean analyst price target is $285, against a close of $302. That gap — stock above the Street's midpoint — is a direct consequence of a 31% monthly rally that analysts are still scrambling to reflect. Mizuho's Vijay Rakesh raised his target this week to $300, still trailing the current price. The post-earnings wave of upgrades on April 23 — JP Morgan to $280, UBS to $295, TD Cowen to $300 — all landed below where the stock now trades. The direction of travel is unanimously upward: no firm has cut, and the unanimous move has been to raise. But the consensus has been outrun. Factor scores provide supporting texture: analyst recommendation divergence ranks in the 95th percentile, meaning the analyst community's positioning relative to its own history is unusually stretched in the bullish direction. EPS momentum over 30 days ranks 84th percentile.
The insider signal introduced in last week's note has not reversed — it has deepened. CFO Rafael Lizardi sold a combined ~47,700 shares across three transactions on May 14, totalling roughly $14.7 million. An SVP sold $1.5 million the same day. An independent director, Carrie Smith Cox, sold nearly $2.7 million on May 13. These follow CEO Haviv Ilan's $5.6 million sale on May 4. The 90-day net insider flow now reflects approximately $85 million in net selling. Each of these transactions carried a significance score of 2-3 out of 10 — they are not exceptional individually, and many likely reflect pre-scheduled plans — but the cluster persists, and the stock is now higher than when most of them sold. The executives who sold at $280-$308 are watching the stock close at $302.
Positioning from the short side offers almost no drama. Short interest has drifted back up slightly — roughly 2.5% higher week-on-week — but remains at 1.76% of the free float, still near its lowest levels in months. Borrow costs are essentially flat at 0.45% annualised, and lending market availability is the loosest it can register. There is no short-side pressure, no squeeze dynamic, and nothing in the borrow market to suggest a structural change is underway. The short score of 30.6 is flat and unremarkable. Options positioning adds a mildly bullish tilt: the put/call ratio at 0.81 is running nearly 1.4 standard deviations below its 20-day average of 0.92, meaning calls are outweighing puts at an above-average rate. That's the options market reflecting — not predicting — the same momentum that has driven the stock 31% higher in a month.
The most recent earnings print delivered a 21% one-day pop on April 22, the largest post-earnings move in the available history. The five-day follow-through added another 15%. That reaction now anchors the base from which the monthly gain is measured, and it colours how investors are likely to frame the next event. Q2 results are scheduled for July 20. Between now and then, the central question the Street is debating is not whether TXN is a good business — bulls and bears both acknowledge the analog franchise, the industrial exposure, and the capacity build — but whether the multiple is getting ahead of the recovery cycle. At a trailing P/E near 36 and EV/EBITDA around 24.7, the stock is being valued for a meaningful demand rebound in industrial and automotive, the segments that drove the bull case.
Peers have moved strongly but inconsistently this week. STMicroelectronics and Infineon both gained roughly 9-11% on the week — European analog names catching a bid. ON Semiconductor added 1.8% but gave back 3% on Tuesday, and Analog Devices was broadly flat. Microchip Technology fell 6% on the week, the laggard of the group. TXN's 2.4% weekly gain looks measured by comparison, suggesting the outsized monthly move has left less near-term momentum than some of its peers are currently generating. The next recalibration point is whether analyst targets migrate above $302 quickly enough to restore a conventional "return potential" framing — or whether the consensus remains underwater into July results.
See the live data behind this article on ORTEX.
Open TXN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
